%0 Journal Article %J Reumatologia/Rheumatology %@ 0034-6233 %V 50 %N 1 %D 2012 %F Pyka2012 %T The role of anticentromere antibodies in diagnosis of rheumatic and cancer diseases %X Autoantibodies to centromere proteins (CENPs) were first described in 1980 in limited cutaneous SSc (lcSSc) patients. Since that time a number of CENPs have been identified as autoantibody targets in many rheumatic and cancer diseases (Table I, Fig. 1). The general method for detection of anti-centromere antibodies (ACA) is indirect immunofluorescence using HEp-2 cell slides. Autoantibodies CENP-A, -B, -C are relatively specific biomarkers for lcSSc (CREST syndrome). This review focuses on updating information on CENP antibodies against particular autoantigens and their new clinical associations: anti-CENP-A with early Ssc, anti-CENP-D IgM with SLE + Sjögren syndrome, anti-CENP-H (in SSA/SSB negative patients) and anti-CENP-C with Sjögren syndrome. Anti-CENP-F antibodies have totally different clinical significance and occur mainly in cancer diseases. %A Pyka, Joanna %A Horbacz, Iwona %A Biernacka, Elwira %A Ząbek, Jakub %P 52-56 %9 journal article %U https://www.termedia.pl/The-role-of-anticentromere-antibodies-in-diagnosis-of-rheumatic-and-cancer-diseases,18,18301,1,1.html